Eosinophil progenitors in allergy and asthma - Do they matter?

Pharmacology and Therapeutics

Volumn 121, Issue 2, 2009, Pages 174-184

  Rådinger, Madeleine ^a   Lötvall, Jan ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Allergic inflammation; CCR3; Eosinophil progenitor cells; Hematopoiesis; Therapy

Indexed keywords

CHEMOKINE RECEPTOR CCR3; INTERLEUKIN 5;

ALLERGY; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL DIFFERENTIATION; CELL MIGRATION; EOSINOPHIL; EOSINOPHILIA; HEMATOPOIESIS; HUMAN; INFLAMMATION; INFLAMMATORY CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; ASTHMA; BONE MARROW; DRUG DELIVERY SYSTEMS; EOSINOPHILS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; HYPERSENSITIVITY; LUNG; SIGNAL TRANSDUCTION;

EID: 59849087616     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2008.10.008     Document Type: Review

References (150)

1. Asquith K.L., Ramshaw H.S., Hansbro P.M., Beagley K.W., Lopez A.F., and Foster P.S. The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation. J Immunol 180 (2008) 1199-1206
2. Baatjes A.J., Sehmi R., Saito H., Cyr M.M., Dorman S.C., Inman M.D., et al. Anti-allergic therapies: effects on eosinophil progenitors. Pharmacol Ther 95 (2002) 63-72
3. Bautz F., Denzlinger C., Kanz L., and Mohle R. Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1. Blood 97 (2001) 3433-3440
4. Beasley R., Crane J., Lai C.K., and Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol 105 2 Pt 2 (2000) S466-472
5. Bochner B.S., and Schleimer R.P. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 94 3 Pt 1 (1994) 427-438
6. Braccioni F., Dorman S.C., O'Byrne P.M., Inman M.D., Denburg J.A., Parameswaran K., et al. The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects. J Allergy Clin Immunol 110 (2002) 96-101
7. Broide D.H., Paine M.M., and Firestein G.S. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 90 (1992) 1414-1424
8. Cameron L., Christodoulopoulos P., Lavigne F., Nakamura Y., Eidelman D., McEuen A., et al. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor. J Immunol 164 (2000) 1538-1545
9. Chae S.C., Lee Y.C., Park Y.R., Shin J.S., Song J.H., Oh G.J., et al. Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil. Biochem Biophys Res Commun 320 (2004) 131-137
10. Chae S.C., Park Y.R., Oh G.J., Lee J.H., and Chung H.T. The suggestive association of eotaxin-2 and eotaxin-3 gene polymorphisms in Korean population with allergic rhinitis. Immunogenetics 56 (2005) 760-764
11. Coffman R.L., Seymour B.W., Hudak S., Jackson J., and Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245 (1989) 308-310
12. Collins P.D., Marleau S., Griffiths-Johnson D.A., Jose P.J., and Williams T.J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182 (1995) 1169-1174
13. Cromwell O., Moqbel R., Fitzharris P., Kurlak L., Harvey C., Walsh G.M., et al. Leukotriene C4 generation from human eosinophils stimulated with IgG-Aspergillus fumigatus antigen immune complexes. J Allergy Clin Immunol 82 (1988) 535-543
14. Daugherty B.L., Siciliano S.J., DeMartino J.A., Malkowitz L., Sirotina A., and Springer M.S. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 183 (1996) 2349-2354
15. De Lucca G.V., Kim U.T., Vargo B.J., Duncia J.V., Santella III J.B., Gardner D.S., et al. Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency. J Med Chem 48 (2005) 2194-2211
16. Denburg J.A., Sehmi R., Saito H., Pil-Seob J., Inman M.D., and O'Byrne P.M. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol, 106 5 Suppl (2000) S242-246
17. Denburg J.A., Woolley M., Leber B., Linden M., and O'Byrne P. Basophil and eosinophil differentiation in allergic reactions. J Allergy Clin Immunol 94 6 Pt 2 (1994) 1135-1141
18. Dent G., Hadjicharalambous C., Yoshikawa T., Handy R.L., Powell J., Anderson I.K., et al. Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum. Am J Respir Crit Care Med 169 (2004) 1110-1117
19. Ding C., Li J., and Zhang X. Bertilimumab Cambridge Antibody Technology Group. Curr Opin Investig Drugs 5 (2004) 1213-1218
20. Dorman S.C., Babirad I., Post J., Watson R.M., Foley R., Jones G.L., et al. Progenitor egress from the bone marrow after allergen challenge: role of stromal cell-derived factor 1alpha and eotaxin. J Allergy Clin Immunol 115 (2005) 501-507
21. Dorman S.C., Sehmi R., Gauvreau G.M., Watson R.M., Foley R., Jones G.L., et al. Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. Am J Respir Crit Care Med 169 (2004) 565-572
22. Fairbairn L.J., Cowling G.J., Reipert B.M., and Dexter T.M. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74 (1993) 823-832
23. Farahi N., Cowburn A.S., Upton P.D., Deighton J., Sobolewski A., Gherardi E., et al. Eotaxin-1/CC chemokine ligand 11: a novel eosinophil survival factor secreted by human pulmonary artery endothelial cells. J Immunol 179 (2007) 1264-1273
24. Flood-Page P.T., Menzies-Gow A.N., Kay A.B., and Robinson D.S. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 167 (2003) 199-204
25. Flood-Page P., Menzies-Gow A., Phipps S., Ying S., Wangoo A., Ludwig M.S., et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112 (2003) 1029-1036
26. Forssmann U., Uguccioni M., Loetscher P., Dahinden C.A., Langen H., Thelen M., et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 185 (1997) 2171-2176
27. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., and Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183 (1996) 195-201
28. Foster P.S., Martinez-Moczygemba M., Huston D.P., and Corry D.B. Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease. Pharmacol Ther 94 (2002) 253-264
29. Foster P.S., Mould A.W., Yang M., Mackenzie J., Mattes J., Hogan S.P., et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev 179 (2001) 173-181
30. Fryer A.A., Spiteri M.A., Bianco A., Hepple M., Jones P.W., Strange R.C., et al. The -403 G->A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 1 (2000) 509-514
31. Fujishima H., Fukagawa K., Okada N., Takano Y., Tsubota K., Hirai H., et al. Prostaglandin D2 induces chemotaxis in eosinophils via its receptor CRTH2 and eosinophils may cause severe ocular inflammation in patients with allergic conjunctivitis. Cornea 24 (2005) 66-70
32. Fulkerson P.C., Fischetti C.A., McBride M.L., Hassman L.M., Hogan S.P., and Rothenberg M.E. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci U S A 103 (2006) 16418-16423
33. Garrett J.K., Jameson S.C., Thomson B., Collins M.H., Wagoner L.E., Freese D.K., et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 113 (2004) 115-119
34. Gaspar Elsas M.I., Joseph D., Elsas P.X., and Vargaftig B.B. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol 17 (1997) 404-413
35. Gauvreau G.M., Wood L.J., Sehmi R., Watson R.M., Dorman S.C., Schleimer R.P., et al. The effects of inhaled budesonide on circulating eosinophil progenitors and their expression of cytokines after allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med 162 (2000) 2139-2144
36. Gibson P.G., Dolovich J., Girgis-Gabardo A., Morris M.M., Anderson M., Hargreave F.E., et al. The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors. Clin Exp Allergy 20 (1990) 661-668
37. Gibson P.G., Manning P.J., O'Byrne P.M., Girgis-Gabardo A., Dolovich J., Denburg J.A., et al. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors. Am Rev Respir Dis 143 (1991) 331-335
38. Gibson P.G., Wong B.J., Hepperle M.J., Kline P.A., Girgis-Gabardo A., Guyatt G., et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 22 (1992) 525-532
39. Gleich G.J., and Adolphson C.R. The eosinophilic leukocyte: structure and function. Adv Immunol 39 (1986) 177-253
40. Gleich G.J., and Loegering D.A. Immunobiology of eosinophils. Annu Rev Immunol 2 (1984) 429-459
41. Gleich G.J., Frigas E., Loegering D.A., Wassom D.L., and Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol 123 (1979) 2925-2927
42. Gregory B., Kirchem A., Phipps S., Gevaert P., Pridgeon C., Rankin S.M., et al. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression. J Immunol 170 (2003) 5359-5366
43. Hamelmann E., and Gelfand E.W. IL-5-induced airway eosinophilia-the key to asthma?. Immunol Rev 179 (2001) 182-191
44. Hirai H., Tanaka K., Yoshie O., Ogawa K., Kenmotsu K., Takamori Y., et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193 (2001) 255-261
45. Hogan S.P., Koskinen A., and Foster P.S. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol 75 (1997) 284-288
46. Hogan S.P., Koskinen A., Matthaei K.I., Young I.G., and Foster P.S. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 157 (1998) 210-218
47. Hogan M.B., Piktel D., and Landreth K.S. IL-5 production by bone marrow stromal cells: implications for eosinophilia associated with asthma. J Allergy Clin Immunol 106 (2000) 329-336
48. Hogan M.B., Weissman D.N., Hubbs A.F., Gibson L.F., Piktel D., and Landreth K.S. Regulation of eosinophilopoiesis in a murine model of asthma. J Immunol 171 (2003) 2644-2651
49. Humbles A.A., Conroy D.M., Marleau S., Rankin S.M., Palframan R.T., Proudfoot A.E., et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 186 (1997) 601-612
50. Humbles A.A., Lu B., Friend D.S., Okinaga S., Lora J., Al-Garawi A., et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A 99 (2002) 1479-1484
51. Inman M.D., Denburg J.A., Ellis R., Dahlback M., and O'Byrne P.M. Allergen-induced increase in bone marrow progenitors in airway hyperresponsive dogs: regulation by a serum hemopoietic factor. Am J Respir Cell Mol Biol 15 (1996) 305-311
52. Inman M.D., Ellis R., Wattie J., Denburg J.A., and O'Byrne P.M. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol 21 (1999) 473-479
53. Iwasaki H., Mizuno S., Mayfield R., Shigematsu H., Arinobu Y., Seed B., et al. Identification of eosinophil lineage-committed progenitors in the murine bone marrow. J Exp Med 201 (2005) 1891-1897
54. Jacoby D.B., Gleich G.J., and Fryer A.D. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest 91 (1993) 1314-1318
55. Johansson A.K., Sjostrand M., Tomaki M., Samulesson A.M., and Lotvall J. Allergen stimulates bone marrow CD34(+) cells to release IL-5 in vitro; a mechanism involved in eosinophilic inflammation?. Allergy 59 (2004) 1080-1086
56. Jose P.J., Adcock I.M., Griffiths-Johnson D.A., Berkman N., Wells T.N., Williams T.J., et al. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem Biophys Res Commun 205 (1994) 788-794
57. Jose P.J., Griffiths-Johnson D.A., Collins P.D., Walsh D.T., Moqbel R., Totty N.F., et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179 (1994) 881-887
58. Kay A.B., and Klion A.D. Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome. Immunol Allergy Clin North Am 24 (2004) 645-666
59. Kim Y.K., Nakagawa N., Nakano K., Sulakvelidze I., Dolovich J., and Denburg J. Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids. J Allergy Clin Immunol 100 (1997) 389-399
60. Kim Y.K., Uno M., Hamilos D.L., Beck L., Bochner B., Schleimer R., et al. Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids. Am J Respir Cell Mol Biol 20 (1999) 388-397
61. Kips J.C., O'Connor B.J., Langley S.J., Woodcock A., Kerstjens H.A., Postma D.S., et al. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med 167 (2003) 1655-1659
62. Kita H. The eosinophil: a cytokine-producing cell?. J Allergy Clin Immunol 97 (1996) 889-892
63. Koury M.J. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20 (1992) 391-394
64. Krause D.S., Fackler M.J., Civin C.I., and May W.S. CD34: structure, biology, and clinical utility. Blood 87 (1996) 1-13
65. Kucia M., Jankowski K., Reca R., Wysoczynski M., Bandura L., Allendorf D.J., et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35 (2004) 233-245
66. Kuo H.P., Wang C.H., Lin H.C., Hwang K.S., Liu S.L., and Chung K.F. Interleukin-5 in growth and differentiation of blood eosinophil progenitors in asthma: effect of glucocorticoids. Br J Pharmacol 134 (2001) 1539-1547
67. Lamkhioued B., Abdelilah S.G., Hamid Q., Mansour N., Delespesse G., and Renzi P.M. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells. J Immunol 170 (2003) 537-547
68. Lanza F., Healy L., and Sutherland D.R. Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents 15 (2001) 1-13
69. Leckie M.J., ten Brinke A., Khan J., Diamant Z., O'Connor B.J., Walls C.M., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356 (2000) 2144-2148
70. Lee J.J., McGarry M.P., Farmer S.C., Denzler K.L., Larson K.A., Carrigan P.E., et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 185 (1997) 2143-2156
71. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., and Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 111 (2003) 187-196
72. Lim K.G., Wan H.C., Resnick M., Wong D.T., Cruikshank W.W., Kornfeld H., et al. Human eosinophils release the lymphocyte and eosinophil active cytokines, RANTES and lymphocyte chemoattractant factor. Int Arch Allergy Immunol 107 (1995) 342
73. Liu L.Y., Sedgwick J.B., Bates M.E., Vrtis R.F., Gern J.E., Kita H., et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J Immunol 169 (2002) 6452-6458
74. Liu L.Y., Sedgwick J.B., Bates M.E., Vrtis R.F., Gern J.E., Kita H., et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process. J Immunol 169 (2002) 6459-6466
75. Lopez A.F., Begley C.G., Williamson D.J., Warren D.J., Vadas M.A., and Sanderson C.J. Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J Exp Med 163 (1986) 1085-1099
76. Lopez A.F., Williamson D.J., Gamble J.R., Begley C.G., Harlan J.M., Klebanoff S.J., et al. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 78 (1986) 1220-1228
77. Ma W., Bryce P.J., Humbles A.A., Laouini D., Yalcindag A., Alenius H., et al. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 109 (2002) 621-628
78. Makowska J.S., Grzegorczyk J., Bienkiewicz B., Wozniak M., and Kowalski M.L. Systemic responses after bronchial aspirin challenge in sensitive patients with asthma. J Allergy Clin Immunol 121 (2008) 348-354
79. Mathur M., Herrmann K., Li X., Qin Y., Weinstock J., Elliott D., et al. TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma. Am J Respir Crit Care Med 159 (1999) 580-587
80. Mayani H., Guilbert L.J., and Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur J Haematol 49 (1992) 225-233
81. McNagny K., and Graf T. Making eosinophils through subtle shifts in transcription factor expression. J Exp Med 195 (2002) F43-47
82. McNagny K.M., Sieweke M.H., Doderlein G., Graf T., and Nerlov C. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1. Embo J 17 (1998) 3669-3680
83. Menzies-Gow A.N., Flood-Page P.T., Robinson D.S., and Kay A.B. Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non-asthmatic volunteers. Clin Exp Allergy 37 (2007) 1023-1032
84. Menzies-Gow A., Flood-Page P., Sehmi R., Burman J., Hamid Q., Robinson D.S., et al. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 111 (2003) 714-719
85. Menzies-Gow A., Ying S., Sabroe I., Stubbs V.L., Soler D., Williams T.J., et al. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol 169 (2002) 2712-2718
86. Minshall E.M., Schleimer R., Cameron L., Minnicozzi M., Egan R.W., Gutierrez-Ramos J.C., et al. Interleukin-5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge. Am J Respir Crit Care Med 158 (1998) 951-957
87. Miyahara N., Takeda K., Miyahara S., Matsubara S., Koya T., Joetham A., et al. Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness. Am J Respir Crit Care Med 172 (2005) 161-167
88. Mould A.W., Matthaei K.I., Young I.G., and Foster P.S. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 99 (1997) 1064-1071
89. Murali P.S., Kurup V.P., Guo J., and Fink J.N. Development of bone marrow eosinophilia in mice induced by Aspergillus fumigatus antigens. Clin Immunol Immunopathol 84 (1997) 216-220
90. Nakamura H., Luster A.D., Nakamura T., In K.H., Sonna L.A., Deykin A., et al. Variant eotaxin: its effects on the asthma phenotype. J Allergy Clin Immunol 108 (2001) 946-953
91. O'Byrne P.M., Inman M.D., and Parameswaran K. The trials and tribulations of IL-5, eosinophils, and allergic asthma. J Allergy Clin Immunol 108 (2001) 503-508
92. Ohkawara Y., Lei X.F., Stampfli M.R., Marshall J.S., Xing Z., and Jordana M. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol 16 (1997) 510-520
93. Otsuka H., Dolovich J., Befus A.D., Telizyn S., Bienenstock J., and Denburg J.A. Basophilic cell progenitors, nasal metachromatic cells, and peripheral blood basophils in ragweed-allergic patients. J Allergy Clin Immunol 78 (1986) 365-371
94. Palframan R.T., Collins P.D., Severs N.J., Rothery S., Williams T.J., and Rankin S.M. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med 188 (1998) 1621-1632
95. Palframan R.T., Collins P.D., Williams T.J., and Rankin S.M. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91 (1998) 2240-2248
96. Parameswaran K., Watson R., Gauvreau G.M., Sehmi R., and O'Byrne P.M. The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma. Am J Respir Crit Care Med 169 (2004) 915-920
97. Phipps S., Lam C.E., Mahalingam S., Newhouse M., Ramirez R., Rosenberg H.F., et al. Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 110 (2007) 1578-1586
98. Piliponsky A.M., Pickholtz D., Gleich G.J., and Levi-Schaffer F. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. J Allergy Clin Immunol 107 (2001) 993-1000
99. Plotz S.G., Simon H.U., Darsow U., Simon D., Vassina E., Yousefi S., et al. Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 349 (2003) 2334-2339
100. Ponath P.D., Qin S., Post T.W., Wang J., Wu L., Gerard N.P., et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 183 (1996) 2437-2448
101. Pope S.M., Zimmermann N., Stringer K.F., Karow M.L., and Rothenberg M.E. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol 175 (2005) 5341-5350
102. Radinger M., Bossios A., Alm A.S., Jeurink P., Lu Y., Malmhall C., et al. Regulation of allergen-induced bone marrow eosinophilopoiesis: role of CD4(+) and CD8(+) T cells. Allergy 62 (2007) 1410-1418
103. Radinger M., Johansson A.K., Sitkauskiene B., Sjostrand M., and Lotvall J. Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. J Allergy Clin Immunol 113 (2004) 1109-1116
104. Radinger M., Sergejeva S., Johansson A.K., Malmhall C., Bossios A., Sjostrand M., et al. Regulatory role of CD8+ T lymphocytes in bone marrow eosinophilopoiesis. Respir Res 7 (2006) 83
105. Rankin S.M., Conroy D.M., and Williams T.J. Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today 6 (2000) 20-27
106. Ravensberg A.J., Ricciardolo F.L., van Schadewijk A., Rabe K.F., Sterk P.J., Hiemstra P.S., et al. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. J Allergy Clin Immunol 115 (2005) 779-785
107. Robinson D.S., Damia R., Zeibecoglou K., Molet S., North J., Yamada T., et al. CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors. Am J Respir Cell Mol Biol 20 (1999) 9-13
108. Robinson D.S., North J., Zeibecoglou K., Ying S., Meng Q., Rankin S., et al. Eosinophil development and bone marrow and tissue eosinophils in atopic asthma. Int Arch Allergy Immunol 118 (1999) 98-100
109. Rosenberg H.F., and Domachowske J.B. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 70 (2001) 691-698
110. Rosenberg H.F., Phipps S., and Foster P.S. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 119 (2007) 1303-1310
111. Rothenberg M.E. Eosinophilia. N Engl J Med 338 (1998) 1592-1600
112. Rothenberg M.E., Luster A.D., Lilly C.M., Drazen J.M., and Leder P. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med 181 (1995) 1211-1216
113. Saito H., Morikawa H., Howie K., Crawford L., Baatjes A.J., Denburg E., et al. Effects of a cysteinyl leukotriene receptor antagonist on eosinophil recruitment in experimental allergic rhinitis. Immunology 113 (2004) 246-252
114. Sanderson C.J. Interleukin-5, eosinophils, and disease. Blood 79 (1992) 3101-3109
115. Sehmi R., Dorman S., Baatjes A., Watson R., Foley R., Ying S., et al. Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology 109 (2003) 536-546
116. Sehmi R., Howie K., Sutherland D.R., Schragge W., O'Byrne P.M., and Denburg J.A. Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects. Am J Respir Cell Mol Biol 15 (1996) 645-655
117. Sehmi R., Wood L.J., Watson R., Foley R., Hamid Q., O'Byrne P.M., et al. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 100 (1997) 2466-2475
118. Sergejeva S., Johansson A.K., Malmhall C., and Lotvall J. Allergen exposure-induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments. Blood 103 (2004) 1270-1277
119. Sergejeva S., Malmhall C., Lotvall J., and Pullerits T. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid. Clin Exp Allergy 35 (2005) 34-38
120. Shalit M., Sekhsaria S., and Malech H.L. Modulation of growth and differentiation of eosinophils from human peripheral blood CD34+ cells by IL5 and other growth factors. Cell Immunol 160 (1995) 50-57
121. Shaw R.J., Cromwell O., and Kay A.B. Preferential generation of leukotriene C4 by human eosinophils. Clin Exp Immunol 56 (1984) 716-722
122. Shinagawa K., Trifilieff A., and Anderson G.P. Involvement of CCR3-reactive chemokines in eosinophil survival. Int Arch Allergy Immunol 130 (2003) 150-157
123. Shinkai A., Yoshisue H., Koike M., Shoji E., Nakagawa S., Saito A., et al. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 163 (1999) 1602-1610
124. Sitkauskiene B., Johansson A.K., Sergejeva S., Lundin S., Sjostrand M., and Lotvall J. Regulation of bone marrow and airway CD34+ eosinophils by interleukin-5. Am J Respir Cell Mol Biol 30 (2004) 367-378
125. Southam D.S., Widmer N., Ellis R., Hirota J.A., Inman M.D., and Sehmi R. Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice. J Allergy Clin Immunol 115 (2005) 95-102
126. Stevenson D.D., and Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 118 (2006) 773-786
127. Szilvassy S.J., and Hoffman R. Enriched hematopoietic stem cells: basic biology and clinical utility. Biol Blood Marrow Transplant 1 (1995) 3-17
128. Tager A.M., Dufour J.H., Goodarzi K., Bercury S.D., von Andrian U.H., and Luster A.D. BLTR mediates leukotriene B(4)-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis. J Exp Med 192 (2000) 439-446
129. Tomaki M., Zhao L.L., Lundahl J., Sjostrand M., Jordana M., Linden A., et al. Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor alpha. J Immunol 165 (2000) 4040-4050
130. Ueda T., Takeno S., Furukido K., Hirakawa K., and Yajin K. Leukotriene receptor antagonist pranlukast suppresses eosinophil infiltration and cytokine production in human nasal mucosa of perennial allergic rhinitis. Ann Otol Rhinol Laryngol 112 (2003) 955-961
131. Vadas M., Lopez A., Gamble J., Khew-Goodall Y., Smith W., Bernard C., et al. Cytokines and allergy. J Allergy Clin Immunol 94 6 Pt 2 (1994) 1289-1293
132. Wang H.B., Ghiran I., Matthaei K., and Weller P.F. Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol 179 (2007) 7585-7592
133. Wang J., Palmer K., Lotvall J., Milan S., Lei X.F., Matthaei K.I., et al. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest 102 (1998) 1132-1141
134. Wegmann M., Goggel R., Sel S., Sel S., Erb K.J., Kalkbrenner F., et al. Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma. Am J Respir Cell Mol Biol 36 (2007) 61-67
135. Weller P.F. Eosinophils: structure and functions. Curr Opin Immunol 6 (1994) 85-90
136. Woerly G., Roger N., Loiseau S., and Capron M. Expression of Th1 and Th2 immunoregulatory cytokines by human eosinophils. Int Arch Allergy Immunol 118 (1999) 95-97
137. Woltmann G., McNulty C.A., Dewson G., Symon F.A., and Wardlaw A.J. Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood 95 (2000) 3146-3152
138. Wood L.J., Inman M.D., Denburg J.A., and O'Byrne P.M. Allergen challenge increases cell traffic between bone marrow and lung. Am J Respir Cell Mol Biol 18 (1998) 759-767
139. Wood L.J., Inman M.D., Watson R.M., Foley R., Denburg J.A., and O'Byrne P.M. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 157 (1998) 99-105
140. Wood L.J., Sehmi R., Dorman S., Hamid Q., Tulic M.K., Watson R.M., et al. Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma. Am J Respir Crit Care Med 166 (2002) 883-889
141. Wood L.J., Sehmi R., Gauvreau G.M., Watson R.M., Foley R., Denburg J.A., et al. An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects. Am J Respir Crit Care Med 159 5 Pt 1 (1999) 1457-1463
142. Woolley M.J., Denburg J.A., Ellis R., Dahlback M., and O'Byrne P.M. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. Am J Respir Cell Mol Biol 11 (1994) 600-606
143. Wright D.E., Bowman E.P., Wagers A.J., Butcher E.C., and Weissman I.L. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 195 (2002) 1145-1154
144. Ying S., Humbert M., Barkans J., Corrigan C.J., Pfister R., Menz G., et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 158 (1997) 3539-3544
145. Ying S., Meng Q., Zeibecoglou K., Robinson D.S., Macfarlane A., Humbert M., et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol 163 (1999) 6321-6329
146. Ying S., Robinson D.S., Meng Q., Barata L.T., McEuen A.R., Buckley M.G., et al. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 163 (1999) 3976-3984
147. Yu C., Cantor A.B., Yang H., Browne C., Wells R.A., Fujiwara Y., et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 195 (2002) 1387-1395
148. Zeibecoglou K., Ying S., Yamada T., North J., Burman J., Bungre J., et al. Increased mature and immature CCR3 messenger RNA+ eosinophils in bone marrow from patients with atopic asthma compared with atopic and nonatopic control subjects. J Allergy Clin Immunol 103 1 Pt 1 (1999) 99-106
149. Zimmermann N., Hershey G.K., Foster P.S., and Rothenberg M.E. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 111 (2003) 227-242
150. Zimmermann N., Hogan S.P., Mishra A., Brandt E.B., Bodette T.R., Pope S.M., et al. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 165 (2000) 5839-5846